U.S. Court of Appeals for the Federal Circuit, 2023

Astrazeneca Ab v. Mylan Pharmaceuticals Inc.

Astrazeneca Ab v. Mylan Pharmaceuticals Inc.
U.S. Court of Appeals for the Federal Circuit · Decided March 7, 2023

Astrazeneca Ab v. Mylan Pharmaceuticals Inc.

Opinion

Case: 23-1164 Document: 65 Page: 1 Filed: 03/07/2023

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, Plaintiffs-Appellants v. MYLAN PHARMACEUTICALS INC., KINDEVA DRUG DELIVERY L.P., Defendants-Appellees ______________________ 2023-1164 ______________________ Appeal from the United States District Court for the Northern District of West Virginia in Nos. 1:18-cv-00193- IMK-RWT, 1:19-cv-203-IMK-RWT, Judge Irene M. Keeley. ______________________ ON MOTION ______________________ PER CURIAM.

ORDER The parties jointly move to remand the above-cap- tioned appeal with each side to bear its own costs and fees.

Upon consideration thereof, IT IS ORDERED THAT: Case: 23-1164 Document: 65 Page: 2 Filed: 03/07/2023

2 ASTRAZENECA AB v. MYLAN PHARMACEUTICALS INC.

The motion is granted.

FOR THE COURT March 7, 2023 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

ISSUED AS A MANDATE: March 7, 2023

Case-law data current through December 31, 2025. Source: CourtListener bulk data.